HomeCompareMNVAX vs PM

MNVAX vs PM: Dividend Comparison 2026

MNVAX yields 7.23% · PM yields 3.48%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PM wins by $17.3K in total portfolio value
10 years
MNVAX
MNVAX
● Live price
7.23%
Share price
$27.21
Annual div
$1.97
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32.3K
Annual income
$1,144.48
Full MNVAX calculator →
PM
Philip Morris International
● Live price
3.48%
Share price
$165.34
Annual div
$5.76
5Y div CAGR
17.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$2,492.02
Full PM calculator →

Portfolio growth — MNVAX vs PM

📍 PM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMNVAXPM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MNVAX + PM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MNVAX pays
PM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MNVAX
Annual income on $10K today (after 15% tax)
$614.76/yr
After 10yr DRIP, annual income (after tax)
$972.81/yr
PM
Annual income on $10K today (after 15% tax)
$296.12/yr
After 10yr DRIP, annual income (after tax)
$2,118.22/yr
At 15% tax rate, PM beats the other by $1,145.41/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MNVAX + PM for your $10,000?

MNVAX: 50%PM: 50%
100% PM50/50100% MNVAX
Portfolio after 10yr
$40.9K
Annual income
$1,818.25/yr
Blended yield
4.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PM right now

MNVAX
No analyst data
PM
Analyst Ratings
17
Buy
7
Hold
1
Sell
Consensus: Buy
Price Target
$194.30
+17.5% upside vs current
Range: $180.00 — $205.00
Altman Z
4.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MNVAX buys
0
PM buys
0
No recent congressional trades found for MNVAX or PM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMNVAXPM
Forward yield7.23%3.48%
Annual dividend / share$1.97$5.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17.2%
Portfolio after 10y$32.3K$49.6K
Annual income after 10y$1,144.48$2,492.02
Total dividends collected$9.4K$11.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: MNVAX vs PM ($10,000, DRIP)

YearMNVAX PortfolioMNVAX Income/yrPM PortfolioPM Income/yrGap
1← crossover$11,423$723.25$11,648$408.29$225.00PM
2$12,995$772.14$13,589$495.90$594.00PM
3$14,726$820.91$15,877$603.21$1.2KPM
4$16,626$869.38$18,580$734.88$2.0KPM
5$18,707$917.35$21,781$896.75$3.1KPM
6$20,981$964.65$25,578$1,096.12$4.6KPM
7$23,461$1,011.14$30,092$1,342.17$6.6KPM
8$26,160$1,056.68$35,470$1,646.46$9.3KPM
9$29,092$1,101.16$41,892$2,023.58$12.8KPM
10$32,273$1,144.48$49,578$2,492.02$17.3KPM

MNVAX vs PM: Complete Analysis 2026

MNVAXStock

The fund seeks to achieve its investment objective by investing in the common stock of established, high-quality companies selected via bottom-up fundamental analysis. Under normal market conditions, it will maintain at least 80% of its net assets (including borrowings for investment purposes) in such securities. The fund may also invest up to 35% of its assets in foreign securities (including American Depositary Receipts and emerging market securities). To the extent invested in common stocks, the fund generally invests in only 25-40 companies at any given time.

Full MNVAX Calculator →

PMConsumer Staples

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Full PM Calculator →
📬

Get this MNVAX vs PM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MNVAX vs SCHDMNVAX vs JEPIMNVAX vs OMNVAX vs KOMNVAX vs MAINMNVAX vs MOMNVAX vs BTIMNVAX vs PEP

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.